ArticleSurgery open science2025
Outcomes of simultaneous resection for colorectal liver metastases: A nationwide cohort study (2005-2022).
Article in Surgery open science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The optimal treatment strategy for synchronous colorectal liver metastases (CRLM) has been a topic for ongoing debate. We present a national cohort containing simultaneous resections of the primary tumour and CRLM, with emphasis on postoperative complications, and survival. Method: This population-based national cohort study included consecutive patients who underwent simultaneous resections in Norway between 2005 and 2022. Postoperative complications (Accordion Severity Grading System - ASGS) and overall survival (OS) were analysed in relation to the extent of liver resection and location of the primary tumour. Results: A total of 193 patients underwent simultaneous resection of the primary tumour and liver metastases. Postoperative complications graded as ASGS ≥3 occurred in 48 (24.9 %) while 23 (11.9 %) patients developed ASGS ≥4 complications. Anastomotic leakage was observed in 9 (4.7 %) patients. Among 18 (9.3 %) patients undergoing major liver resections, 10 (55.6 %) and seven (38.9 %) patients experienced ASGS ≥3 and ASGS ≥4 complications, respectively. Major liver resection was an independent predictor for ASGS ≥3, (RR: 2.40; p = 0.002). The 30- and 90-day mortality rates were 0.5 % (n = 1) and 2.1 % (n = 4), respectively. Median, 5- and 10-year OS were 4.8 years, 46.7 % and 35.6 %, respectively. In a multivariable analysis both an increasing number of liver metastases and ASGS ≥4 complications were independently associated with inferior OS. Conclusions: Simultaneous resection for synchronous CRLM was a safe option, particularly in minor liver resections. Major liver resections were associated with increased risk of severe complications and inferior OS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.